DK4346847T3 - Pluri-ionisk kompleks til anvendelse i forebyggelse eller behandling af neurogen inflammation - Google Patents

Pluri-ionisk kompleks til anvendelse i forebyggelse eller behandling af neurogen inflammation

Info

Publication number
DK4346847T3
DK4346847T3 DK22732150.2T DK22732150T DK4346847T3 DK 4346847 T3 DK4346847 T3 DK 4346847T3 DK 22732150 T DK22732150 T DK 22732150T DK 4346847 T3 DK4346847 T3 DK 4346847T3
Authority
DK
Denmark
Prior art keywords
pluri
prevention
treatment
ionic complex
neurogenic inflammation
Prior art date
Application number
DK22732150.2T
Other languages
English (en)
Inventor
Wesepoel Philippe Van
Jean-François Plucker
Original Assignee
Olys Pharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olys Pharma Srl filed Critical Olys Pharma Srl
Application granted granted Critical
Publication of DK4346847T3 publication Critical patent/DK4346847T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK22732150.2T 2021-06-04 2022-06-03 Pluri-ionisk kompleks til anvendelse i forebyggelse eller behandling af neurogen inflammation DK4346847T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE20215448A BE1029458B1 (fr) 2021-06-04 2021-06-04 Complexe pluri-ionique pour la prévention ou le traitement de l'inflammation neurogène
PCT/EP2022/065271 WO2022254042A1 (en) 2021-06-04 2022-06-03 Pluri-ionic complex for the prevention or treatment of neurogenic inflammation

Publications (1)

Publication Number Publication Date
DK4346847T3 true DK4346847T3 (da) 2025-10-20

Family

ID=76325316

Family Applications (1)

Application Number Title Priority Date Filing Date
DK22732150.2T DK4346847T3 (da) 2021-06-04 2022-06-03 Pluri-ionisk kompleks til anvendelse i forebyggelse eller behandling af neurogen inflammation

Country Status (10)

Country Link
US (1) US20240261323A1 (da)
EP (1) EP4346847B1 (da)
JP (1) JP2024520753A (da)
CN (1) CN117479948A (da)
BE (1) BE1029458B1 (da)
DK (1) DK4346847T3 (da)
ES (1) ES3047741T3 (da)
PL (1) PL4346847T3 (da)
PT (1) PT4346847T (da)
WO (1) WO2022254042A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1030588B1 (fr) * 2022-06-03 2024-01-08 Ynios Pharma Complexe pluri-ionique pour la prévention ou le traitement de l'inflammation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639625A (en) * 1967-07-13 1972-02-01 Lewis Sherwin Compositions containing lithium succinate
GB8318912D0 (en) * 1983-07-13 1983-08-17 Horrobin D F Compositions for treatment of skin/hair
JPH0753389A (ja) * 1993-08-12 1995-02-28 Isao Ishida 浴用剤
US5516534A (en) * 1993-11-26 1996-05-14 Rensselaer Polytechnic Institute Composition and method for reducing structural defects
JPH07238004A (ja) * 1994-02-24 1995-09-12 Asao Shimanishi 殺菌消毒剤
US6572902B2 (en) * 2001-04-25 2003-06-03 Advanced H2O, Inc. Process for producing improved alkaline drinking water and the product produced thereby
US7300649B2 (en) * 2005-02-11 2007-11-27 Genepharm, Inc. Cosmetic and cosmeceutical compositions for restoration of skin barrier function
FR2893501B1 (fr) * 2005-11-21 2014-03-14 Oreal Compositions topiques pour favoriser l'homeostasie de la peau
US20110189309A1 (en) * 2007-07-12 2011-08-04 Whipbird Pain Relief Pty Ltd Acn 132 827 411 Topical medicament
AU2008274908B2 (en) * 2008-07-11 2014-08-14 Whipbird Pain Relief Pty Ltd Topical medicament
JP4524715B2 (ja) * 2008-07-14 2010-08-18 広島化成株式会社 ミネラル含有加水素水およびその製造方法
JP2010116327A (ja) * 2008-11-11 2010-05-27 Hayashibara Biochem Lab Inc ミネラル調整水
US9750764B2 (en) * 2008-12-09 2017-09-05 Warburton Technology Limited Trace elements
KR100943204B1 (ko) * 2009-07-14 2010-02-19 주식회사메자이텍 혈액순환 개선용 기능성 음용수 및 이의 제조방법
ES2476240T3 (es) * 2010-12-30 2018-03-06 Aktsionernoye Obshchestvo "Nauchnyi Tsentr Protivoinfektsionnyh Preparatov" Agente antibacteriano para el tratamiento de enfermedades infecciosas de origen bacteriano
KR101326472B1 (ko) * 2011-11-28 2013-11-08 가톨릭대학교 산학협력단 광천수를 함유한 비강 세척용 조성물
KR101439206B1 (ko) * 2013-11-18 2014-09-12 주식회사 에네스티 수안보 온천수를 이용한 피부개선 화장료 조성물
ES2651717B1 (es) * 2016-07-26 2018-11-16 Lara OLLER DUQUE Solución acuosa cristaloide isotónica
CN108310287A (zh) * 2018-04-26 2018-07-24 深圳安济堂医药科技有限公司 治疗癌症的口服液及其制备方法
KR102187895B1 (ko) * 2019-03-12 2020-12-07 가톨릭대학교 산학협력단 대사성 질환의 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
EP4346847A1 (en) 2024-04-10
JP2024520753A (ja) 2024-05-24
BE1029458B1 (fr) 2023-01-09
WO2022254042A1 (en) 2022-12-08
EP4346847B1 (en) 2025-09-17
US20240261323A1 (en) 2024-08-08
PL4346847T3 (pl) 2025-12-01
BE1029458A1 (fr) 2023-01-05
PT4346847T (pt) 2025-10-23
ES3047741T3 (en) 2025-12-04
CN117479948A (zh) 2024-01-30

Similar Documents

Publication Publication Date Title
DK4028010T3 (da) Vs-6063 i kombination med ch5126766 til behandlingen af kræft
DK3593817T3 (da) Sammensætning til anvendelse til forebyggelse eller undertrykkelse af nærsynethed
DK3860990T3 (da) Inhibitorer for YAP/TAZ-TEAD interaktion og disses anvendelse ved behandlingen af cancer
DK3897833T3 (da) Hæmmere af APOL1 og fremgangsmåder til anvendelse heraf
DK3687576T3 (da) Anvendelse af cannabidiol i kombination med norfenfluramin eller fenfluramin i behandling af epilepsi
DK4014976T3 (da) Aprocitentan til anvendelse i behandlingen af hypertension og relaterede sygdomme i kombination med valsartan
DK3713554T3 (da) Doseringsanvisninger for vidofludimus til behandling af kroniske inflammatoriske og/eller autoimmunsygdomme
DK3962601T3 (da) 5-HT2A-agonister til anvendelse til behandling af depression
DK3806898T3 (da) Gremlin-1-antagonist til anvendelse i behandling af cancer
DK4327866T3 (da) Mirikizumab ved behandling af ulcerøs kolitis
DK3982924T3 (da) Planteekstraktblanding til anvendelse ved forebyggelse og/eller behandling af kroniske inflammatoriske tarmsygdomme
DK3395359T5 (da) Plasminogen til anvendelse til forebyggelse eller behandling af akut trombose og kronisk trombose
DK3972643T3 (da) Komplementsystemantagonister til anvendelse i fremgangsmåder til behandling af paraproteinemiske neuropatier
DK4005570T3 (da) Pridopidin til anvendelse behandling af retts syndroe
MA49248A (fr) Inhibiteurs de fgfr2 utilisés dans le traitement du cholangiocarcinome
DK3362449T3 (da) Sibirilin-derivater til anvendelse til at forebygge og/eller behandle lidelser associeret med cellulær nekroptose
DK3570940T3 (da) Pridopidin til anvendelse i behandling af fragilt x-syndrom
DK3442547T3 (da) Lactobacillus reuteri MM4-1A til anvendelse i behandling eller forebyggelse af autismespektrumforstyrrelser
DK3522904T3 (da) Flydende sammensætning til anvendelse i behandlingen af gastroesophageal reflux
IL289758A (en) Ferroportin-inhibitors for the use in the prevention and treatment of kidney injuries
DK3592355T3 (da) KX2-391/KX-01 til anvendelse i behandling af aktinisk keratose
DK3519411T3 (da) Heterocykliske forbindelser og deres anvendelse inden for forebyggelsen eller behandlingen af bakterieinfektioner
DK4419526T3 (da) Heterocykliske forbindelser til anvendelse i behandlingen af cancer
DK4340842T3 (da) Sotorasib til anvendelse ved behandling af kræft
DK3773615T3 (da) Flydende sammensætning til anvendelse ved behandling af slimhinden i munden-svælget-struben-spiserøret